{"id":"NCT03476239","sponsor":"Amgen","briefTitle":"Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)","officialTitle":"An Open-label, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-18","primaryCompletion":"2019-08-21","completion":"2021-04-08","firstPosted":"2018-03-26","resultsPosted":"2020-09-14","lastUpdate":"2023-02-08"},"enrollment":121,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Lymphoblastic Leukemia"],"interventions":[{"type":"DRUG","name":"Blinatumomab","otherNames":["BLINCYTOÂ®","AMG 103","MT103"]},{"type":"DRUG","name":"Dexamthasone","otherNames":[]}],"arms":[{"label":"Blinatumomab","type":"EXPERIMENTAL"}],"summary":"This study is being done to evaluate the rate of hematological response (complete remission/complete remission with partial hematological recovery \\[CR/CRh\\*\\]) induced by blinatumomab in Chinese adults with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL).","primaryOutcome":{"measure":"Percentage of Participants With a Hematological Response of Complete Remission (CR) or Complete Remission With Partial Hematological Recovery (CRh*) During the First 2 Treatment Cycles With Blinatumomab","timeFrame":"Within 2 cycles of treatment (12 weeks)","effectByArm":[{"arm":"Blinatumomab","deltaMin":45.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":33},"locations":{"siteCount":23,"countries":["China"]},"refs":{"pmids":["36000952"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":120},"commonTop":["Anaemia","Cytokine release syndrome","White blood cell count decreased","Hypokalaemia","C-reactive protein increased"]}}